Cargando…

Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea

OBJECTIVES: This study was designed to investigate changes in health-related quality of life (HRQoL) of patients with acromegaly in Korea after medical treatment with octreotide LAR using the validated Korean version of the acromegaly quality of life questionnaire (AcroQoL). DESIGN: A prospective, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin, Sang Ouk, Chung, Choon Hee, Chung, Yoon-Sok, Kim, Byung-Joon, Kim, Hee Young, Kim, In-Ju, Kim, Jung Guk, Kim, Min-Seon, Kim, Seong-Yeon, Lee, Eun Jig, Lee, Ki Young, Kim, Sung-Woon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466761/ https://www.ncbi.nlm.nih.gov/pubmed/26063564 http://dx.doi.org/10.1136/bmjopen-2014-006898

Ejemplares similares

Acromegaly Quality of Life Questionnaire (AcroQoL)
por: Badia, Xavier, et al.
Publicado: (2004)

Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population
por: Danaei, Mina, et al.
Publicado: (2022)

Improved AcroQoL scores in acromegaly after sagittal split ramus osteotomy with Le Fort I osteotomy
por: Taguchi, Tomomi, et al.
Publicado: (2021)

Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly
por: Tutuncu, Yasemin, et al.
Publicado: (2011)

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly
por: Mercado, Moises, et al.
Publicado: (2007)

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
por: Neggers, Sebastian JCMM, et al.
Publicado: (2015)

AcroVoice: eliciting the patients’ perspective on acromegaly disease activity
por: Jackson, Yanina, et al.
Publicado: (2019)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
por: Chin, Sang Ouk, et al.
Publicado: (2019)

Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR
por: Porto, Lara Benigno, et al.
Publicado: (2018)

Development of a novel patient-reported measure for acromegaly: the Acro-TSQ
por: Fleseriu, Maria, et al.
Publicado: (2019)

ACRODAT® and AcroVoice: an insight into a holistic approach to the management of acromegaly
por: Lundie, Mark, et al.
Publicado: (2019)

Effect of Zoledronic Acid on Acro-Osteolysis and Osteoporosis in a Patient with Hajdu-Cheney Syndrome
por: Hwang, Sena, et al.
Publicado: (2011)

Octreotide-Resistant Acromegaly: Challenges and Solutions
por: Corica, Giuliana, et al.
Publicado: (2020)

Everolimus in combination with octreotide LAR in thymic atypical carcinoid
por: Sakane, Tadashi, et al.
Publicado: (2023)

Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study
por: Caron, Philippe, et al.
Publicado: (2018)

SAT-435 Optimization of Pharmacological Treatment of Acromegaly: Impact on IGF-1 Levels Comparing Isolated Octreotide LAR and Combined Pharmacological Therapy
por: Naves, Luciana, et al.
Publicado: (2019)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
por: Kim, Kyungwon, et al.
Publicado: (2023)

Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers
por: Tiberg, Fredrik, et al.
Publicado: (2015)

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study
por: Caron, Philippe, et al.
Publicado: (2018)

Characteristics of Acromegaly in Korea with a Literature Review
por: Hong, Jae Won, et al.
Publicado: (2013)

Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
por: Giustina, Andrea, et al.
Publicado: (2012)

GH Secretory Dynamics and Responsiveness to SMS 201-995 Treatment in Acromegaly
por: Kim, Sung Woon, et al.
Publicado: (1988)

Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Antidiabetic Effects of NRDT50, the Enzyme Composition for Regulating Sugar Metabolism, in Db/db Mice
por: Kim, Daham, et al.
Publicado: (2021)

Acro-osteolysis
por: Thomas, Joe, et al.
Publicado: (2019)

Prevalence of metabolic syndrome and its related factors among North Korean refugees in South Korea: a cross-sectional study
por: Kim, Yoon Jung, et al.
Publicado: (2016)

Using Growth Hormone Levels to Detect Macroadenoma in Patients with Acromegaly
por: Park, Ji Young, et al.
Publicado: (2014)

SAT-436 Adjuvant Therapeutic Modalities in Acromegaly: Clinical Course and Factors Predicting Biochemical Controls
por: Jung, Hyein, et al.
Publicado: (2019)

Acro-osteolysis and calcinosis in patient with scleroderma: A case report
por: Choi, Wan-Sun, et al.
Publicado: (2017)

Pharmacokinetic and technical comparison of Sandostatin(® )LAR(® )and other formulations of long-acting octreotide
por: Petersen, Holger, et al.
Publicado: (2011)

Effect of octreotide on endometriosis in acromegaly: Case report with review of literature
por: Singh, Seerat, et al.
Publicado: (2014)

Octreotide use for rescue of vision in a pregnant patient with acromegaly
por: Hannon, Anne Marie, et al.
Publicado: (2019)

Durable biochemical response and safety with oral octreotide capsules in acromegaly
por: Samson, Susan L, et al.
Publicado: (2022)

Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2016)

The Effect of Long Acting Somatostatin Analogue SMS 201-995 in Acromegaly
por: Choi, Chul Joon, et al.
Publicado: (1987)

Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea
por: Hur, Kyu Yeon, et al.
Publicado: (2015)

Prevalence of osteoporosis among North Korean women refugees living in South Korea: a comparative cross-sectional study
por: Kim, Kyeong Jin, et al.
Publicado: (2020)

Predictive values of neutrophil-lymphocyte ratio as an early indicator for severe acute pancreatitis in the emergency department patients
por: Park, Hyun Sok, et al.
Publicado: (2019)

Acromegaly due to a Macroinvasive Plurihormonal Pituitary Adenoma and a Rectal Carcinoid Tumor
por: Chin, Sang Ouk, et al.
Publicado: (2015)

Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
por: Gariani, Karim, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h72iq26rc115g3b2u9nluu5235